Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

BACKGROUND: Olanzapine long-acting injection (LAI) is a salt-based depot antipsychotic combining olanzapine and pamoic acid. The slow intramuscular dissolution of this practically insoluble salt produces an extended release of olanzapine lasting up to 4 weeks. However, in a small number of injection...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: McDonnell, David P, Detke, Holland C, Bergstrom, Richard F, Kothare, Prajakti, Johnson, Jason, Stickelmeyer, Mary, Sanchez-Felix, Manuel V, Sorsaburu, Sebastian, Mitchell, Malcolm I
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895590/
https://ncbi.nlm.nih.gov/pubmed/20537130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-10-45
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares